Title: PCB95 and PCB153 change dopamine levels and turn-over in PC12 cells.
Journal: Toxicology 20180201
Title: Co-morbidity and self medication in schizophrenia: involvement of endogenous morphine signaling mechanisms.
Journal: Current drug targets 20121001
Title: Catechol and aldehyde moieties of 3,4-dihydroxyphenylacetaldehyde contribute to tyrosine hydroxylase inhibition and neurotoxicity.
Journal: Brain research 20120920
Title: Expression and purification of recombinant human tyrosine hydroxylase as a fusion protein in Escherichia coli.
Journal: Protein expression and purification 20120801
Title: Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.
Journal: PloS one 20120101
Title: Inflammatory Pathways in Parkinson's Disease; A BNE Microarray Study.
Journal: Parkinson's disease 20120101
Title: Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease.
Journal: PloS one 20120101
Title: Schisandrin B as a hormetic agent for preventing age-related neurodegenerative diseases.
Journal: Oxidative medicine and cellular longevity 20120101
Title: Functional significance of aldehyde dehydrogenase ALDH1A1 to the nigrostriatal dopamine system.
Journal: Brain research 20110823
Title: Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite.
Journal: Neurotoxicology 20110801
Title: Oxidation of 3,4-dihydroxyphenylacetaldehyde, a toxic dopaminergic metabolite, to a semiquinone radical and an ortho-quinone.
Journal: The Journal of biological chemistry 20110729
Title: Dopamine-derived biological reactive intermediates and protein modifications: Implications for Parkinson's disease.
Journal: Chemico-biological interactions 20110630
Title: Oxidative stress in schizophrenia.
Journal: Current neuropharmacology 20110601
Title: Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties.
Journal: British journal of cancer 20110510
Title: Catechols in post-mortem brain of patients with Parkinson disease.
Journal: European journal of neurology 20110501
Title: Natural toxin implicated as triggering Parkinson's disease.
Journal: Pakistan journal of biological sciences : PJBS 20110201
Title: From L-dopa to dihydroxyphenylacetaldehyde: a toxic biochemical pathway plays a vital physiological function in insects.
Journal: PloS one 20110101
Title: The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease.
Journal: International journal of molecular sciences 20110101
Title: The evolution of dopamine systems in chordates.
Journal: Frontiers in neuroanatomy 20110101
Title: Widespread increases in malondialdehyde immunoreactivity in dopamine-rich and dopamine-poor regions of rat brain following multiple, high doses of methamphetamine.
Journal: Frontiers in systems neuroscience 20110101
Title: Dopamine and α-synuclein dysfunction in Smad3 null mice.
Journal: Molecular neurodegeneration 20110101
Title: [Reactive oxygen species and 3,4-dihydroxyphenylacetaldehyde in pathogenesis of Parkinson disease].
Journal: Przeglad lekarski 20110101
Title: Cellular and mitochondrial effects of alcohol consumption.
Journal: International journal of environmental research and public health 20101201
Title: Relative inhibitory potency of molinate and metabolites with aldehyde dehydrogenase 2: implications for the mechanism of enzyme inhibition.
Journal: Chemical research in toxicology 20101115
Title: Mitochondrial aldehyde dehydrogenase and cardiac diseases.
Journal: Cardiovascular research 20101001
Title: Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis.
Journal: Nature medicine 20100901
Title: Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms.
Journal: Experimental neurobiology 20100901
Title: Catechol-O-methyltransferase: potential relationship to idiopathic hypertension.
Journal: Archives of medical science : AMS 20100630
Title: Contamination of the norepinephrine prodrug droxidopa by dihydroxyphenylacetaldehyde.
Journal: Clinical chemistry 20100501
Title: Complete genome sequence and lifestyle of black-pigmented Corynebacterium aurimucosum ATCC 700975 (formerly C. nigricans CN-1) isolated from a vaginal swab of a woman with spontaneous abortion.
Journal: BMC genomics 20100101
Title: Selective neuronal vulnerability to oxidative stress in the brain.
Journal: Frontiers in aging neuroscience 20100101
Title: Potential redox-sensitive Akt activation by dopamine activates Bad and promotes cell death in melanocytes.
Journal: Oxidative medicine and cellular longevity 20100101
Title: Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.
Journal: Frontiers in neuroanatomy 20100101
Title: The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis.
Journal: PloS one 20100101
Title: Nitrative and oxidative stress in toxicology and disease.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20091101
Title: Multiple roles of the active site lysine of Dopa decarboxylase.
Journal: Archives of biochemistry and biophysics 20090815
Title: Protein reactivity of 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and the catechol.
Journal: Chemical research in toxicology 20090701
Title: Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate.
Journal: Chemical research in toxicology 20090501
Title: Dopamine release in the nucleus accumbens (shell) of two lines of rats selectively bred to prefer or avoid ethanol.
Journal: European journal of pharmacology 20071114
Title: Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate.
Journal: Chemical research in toxicology 20071001
Title: A new chromone, 11-hydroxy-sec-O-glucosylhamaudol from Ostericum koreanum.
Journal: Chemical & pharmaceutical bulletin 20070701
Title: Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase.
Journal: Pharmacological reviews 20070601
Title: Functional analysis of norcoclaurine synthase in Coptis japonica.
Journal: The Journal of biological chemistry 20070302
Title: Aspects of cuticular sclerotization in the locust, Scistocerca gregaria, and the beetle, Tenebrio molitor.
Journal: Insect biochemistry and molecular biology 20070301
Title: Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan.
Journal: Progress in neuro-psychopharmacology & biological psychiatry 20070130
Title: Inhibition of the oxidative metabolism of 3,4-dihydroxyphenylacetaldehyde, a reactive intermediate of dopamine metabolism, by 4-hydroxy-2-nonenal.
Journal: Neurotoxicology 20070101
Title: Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra.
Journal: Acta neuropathologica 20060801
Title: [Assessment of the in vitro and in vivo toxicity of 3,4-dihydroxyphenylacetaldehyde (DOPAL)].
Journal: Annales pharmaceutiques francaises 20040901
Title: Toxicity of a treatment associating dopamine and disulfiram for catecholaminergic neuroblastoma SH-SY5Y cells: relationships with 3,4-dihydroxyphenylacetaldehyde formation.
Journal: Neurotoxicology 20040301
Title: Semi-chronic increase in striatal level of 3,4-dihydroxyphenylacetaldehyde does not result in alteration of nigrostriatal dopaminergic neurones.
Journal: Journal of neuroscience research 20040201
Title: Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases.
Journal: Neurotoxicology 20040101
Title: 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis.
Journal: Brain research 20031107
Title: Convenient syntheses of biogenic aldehydes, 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde.
Journal: Bioorganic chemistry 20030401
Title: 3,4-dihydroxyphenylacetaldehyde: a potential target for neuroprotective therapy in Parkinson's disease.
Journal: Current drug targets. CNS and neurological disorders 20030401
Title: Oxidative metabolite of dopamine, 3,4-dihydroxyphenylacetaldehyde, induces dopamine release from PC12 cells by a Ca2+-independent mechanism.
Journal: Brain research 20020322
Title: Novel aspects of dopamine oxidative metabolism (confounding outcomes take place of certainties).
Journal: Pharmacology & toxicology 20011101
Title: 3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis.
Journal: Brain research. Molecular brain research 20010910
Title: Parkinson's disease--redox mechanisms.
Journal: Current medicinal chemistry 20010601
Title: Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria.
Journal: Free radical biology & medicine 20010415
Title: Biogenic aldehyde(s) derived from the action of monoamine oxidase may mediate the antidipsotropic effect of daidzin.
Journal: Chemico-biological interactions 20010130
